Recognition mechanisms of multiple sclerosis antibody MS with antigens EBNA1 and GlialCAM by molecular dynamics simulations

Abstract

Multiple sclerosis (MS), a severe autoimmune disease of the central nervous system (CNS), is marked by detrimental demyelination and axonal destruction. High-affinity molecular mimicry exists between Epstein-Barr virus nuclear antigen 1 (EBNA1) and glial cell adhesion molecule (GlialCAM) in CNS, leading to cross-reactivity of the cerebrospinal fluid B cell-encoded monoclonal antibody (mAb) MS39p2w174 with EBNA1 and GlialCAM. We aim to explore two interesting questions using molecular dynamics simulations in explicit solvent: how does molecular mimicry between the two antigens (Ags) contribute to the cross-reactivity of immune response? What conformational changes occur in the complementarity-determining regions (CDRs) of the mAb upon binding? Remarkably, both Ags are inclined to obey the combination of the induced-fit and the conformational-selection mechanisms by local and global structures analysis and Kolmogorov-Smirnov test, allowing the similar epitopes to be recognized by the same Ab. Conformational characterization suggests the CDR1 loop of mAb light-chain (CDR-L1) experiences significant changes. Binding-energy prediction proves the hydrogen bonds are critical for complex stability, both CDR-L1 and CDR-H3 (heavy-chain CDR3 loop) are important interaction interfaces. The role of CDR-H3 has been verified by previous studies. Furthermore, the distinct characteristics of the bindings of two Ags and Ab are demonstrated. EBNA1 shows higher binding affinity, allowing a precise fit and greater complex stability. In contrast, Glial-CAM undergoes more significant local conformational changes to achieve structural complementarity, compensating for its lower intrinsic affinity. These differences highlight varied molecular recognition strategies underlying antibody specificity and cross-reactivity. The findings provide the deep understanding for the molecular pathogenesis of MS causing by different Ags with high-affinity molecular mimicry, which provide theoretical support for further research.

Supplementary files

Article information

Article type
Paper
Submitted
18 Jul 2025
Accepted
20 Nov 2025
First published
26 Nov 2025

Phys. Chem. Chem. Phys., 2025, Accepted Manuscript

Recognition mechanisms of multiple sclerosis antibody MS with antigens EBNA1 and GlialCAM by molecular dynamics simulations

L. Zhang and Q. Yu, Phys. Chem. Chem. Phys., 2025, Accepted Manuscript , DOI: 10.1039/D5CP02745D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements